These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 19570612)

  • 1. Seroreactivity against raw insect-derived recombinant KMPII, TRYP, and LACK Leishmania infantum proteins in infected dogs.
    Todolí F; Pérez-Filgueira M; Galindo I; Gómez-Sebastián S; Escribano JM; Rodríguez-Cortés A; Alberola J
    Vet Parasitol; 2009 Oct; 164(2-4):154-61. PubMed ID: 19570612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serological evaluation of experimentally infected dogs by LicTXNPx-ELISA and amastigote-flow cytometry.
    Silvestre R; Santarém N; Cunha J; Cardoso L; Nieto J; Carrillo E; Moreno J; Cordeiro-da-Silva A
    Vet Parasitol; 2008 Nov; 158(1-2):23-30. PubMed ID: 18848397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Humoral and in vivo cellular immunity against the raw insect-derived recombinant Leishmania infantum antigens KMPII, TRYP, LACK, and papLe22 in dogs from an endemic area.
    Todolí F; Solano-Gallego L; de Juan R; Morell P; Núñez Mdel C; Lasa R; Gómez-Sebastián S; Escribano JM; Alberola J; Rodríguez-Cortés A
    Am J Trop Med Hyg; 2010 Dec; 83(6):1287-94. PubMed ID: 21118936
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Application of a recombinant protein for the serological diagnosis of canine leishmaniasis.
    Boarino A; Bollo E; Prunotto L; Canale L; Uslenghi F; Poletti P
    Comp Immunol Microbiol Infect Dis; 2008 Nov; 31(6):527-36. PubMed ID: 18262268
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selection of appropriate serological tests to measure the incidence of natural Leishmania infantum infection during DNA/MVA prime/boost canine vaccine trials.
    Carson C; Antoniou M; Christodoulou V; Messaritakis I; Quinnell RJ; Blackwell JM; Courtenay O
    Vet Parasitol; 2009 Jun; 162(3-4):207-13. PubMed ID: 19386420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaccination with plasmid DNA encoding KMPII, TRYP, LACK and GP63 does not protect dogs against Leishmania infantum experimental challenge.
    Rodríguez-Cortés A; Ojeda A; López-Fuertes L; Timón M; Altet L; Solano-Gallego L; Sánchez-Robert E; Francino O; Alberola J
    Vaccine; 2007 Nov; 25(46):7962-71. PubMed ID: 17942199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-lasting protection against canine visceral leishmaniasis using the LiESAp-MDP vaccine in endemic areas of France: double-blind randomised efficacy field trial.
    Lemesre JL; Holzmuller P; Gonçalves RB; Bourdoiseau G; Hugnet C; Cavaleyra M; Papierok G
    Vaccine; 2007 May; 25(21):4223-34. PubMed ID: 17395339
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel exo-antigen-based ELISA for the detection of canine leishmaniasis.
    Rajasekariah GH; Cardoso L; Dogcio DA; Martin SK; Smithyman AM
    Am J Trop Med Hyg; 2008 Apr; 78(4):616-23. PubMed ID: 18385358
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heterologous prime-boost vaccination with a non-replicative vaccinia recombinant vector expressing LACK confers protection against canine visceral leishmaniasis with a predominant Th1-specific immune response.
    Ramos I; Alonso A; Marcen JM; Peris A; Castillo JA; Colmenares M; Larraga V
    Vaccine; 2008 Jan; 26(3):333-44. PubMed ID: 18093705
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advances in flow cytometric serology for canine visceral leishmaniasis: diagnostic applications when distinct clinical forms, vaccination and other canine pathogens become a challenge.
    Andrade RA; Silva Araújo MS; Reis AB; Gontijo CM; Vianna LR; Mayrink W; Martins-Filho OA
    Vet Immunol Immunopathol; 2009 Mar; 128(1-3):79-86. PubMed ID: 19046772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A recombinant cysteine proteinase from Leishmania (Leishmania) chagasi as an antigen for delayed-type hypersensitivity assays and serodiagnosis of canine visceral leishmaniasis.
    Pinheiro PH; Pinheiro AN; Ferreira JH; Costa FA; Katz S; Barbiéri CL
    Vet Parasitol; 2009 May; 162(1-2):32-9. PubMed ID: 19269098
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of enzyme-linked immunosorbent assays, an immunofluorescent-antibody test, and two rapid tests (immunochromatographic-dipstick and gel tests) for serological diagnosis of symptomatic and asymptomatic Leishmania infections in dogs.
    Mettler M; Grimm F; Capelli G; Camp H; Deplazes P
    J Clin Microbiol; 2005 Nov; 43(11):5515-9. PubMed ID: 16272479
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Montenegro's skin reactions and antibodies against different Leishmania species in dogs from a visceral leishmaniosis endemic area.
    Baleeiro CO; Paranhos-Silva M; dos Santos JC; Oliveira GG; Nascimento EG; de Carvalho LP; dos-Santos WL
    Vet Parasitol; 2006 Jun; 139(1-3):21-8. PubMed ID: 16567046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Performance of commercially available serological diagnostic tests to detect Leishmania infantum infection on experimentally infected dogs.
    Rodríguez-Cortés A; Ojeda A; Todolí F; Alberola J
    Vet Parasitol; 2013 Jan; 191(3-4):363-6. PubMed ID: 23021261
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunogenicity of HSP-70, KMP-11 and PFR-2 leishmanial antigens in the experimental model of canine visceral leishmaniasis.
    Carrillo E; Crusat M; Nieto J; Chicharro C; Thomas Mdel C; Martínez E; Valladares B; Cañavate C; Requena JM; López MC; Alvar J; Moreno J
    Vaccine; 2008 Mar; 26(15):1902-11. PubMed ID: 18321614
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Failure of a multi-subunit recombinant leishmanial vaccine (MML) to protect dogs from Leishmania infantum infection and to prevent disease progression in infected animals.
    Gradoni L; Foglia Manzillo V; Pagano A; Piantedosi D; De Luna R; Gramiccia M; Scalone A; Di Muccio T; Oliva G
    Vaccine; 2005 Nov; 23(45):5245-51. PubMed ID: 16054272
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Flow cytometric analysis of cellular immune responses in dogs experimentally infected with a North American isolate of Leishmania infantum.
    Rosypal AC; Gogal RM; Zajac AM; Troy GC; Lindsay DS
    Vet Parasitol; 2005 Jul; 131(1-2):45-51. PubMed ID: 15936890
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dynamics and predictive potential of antibodies against insect-derived recombinant Leishmania infantum proteins during chemotherapy of naturally infected dogs.
    Todolí F; Galindo I; Gómez-Sebastián S; Pérez-Filgueira M; Escribano JM; Alberola J; Rodríguez-Cortés A
    Am J Trop Med Hyg; 2010 May; 82(5):795-800. PubMed ID: 20439957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of two highly performing Leishmania infantum antigens for serodiagnosis of canine leishmaniosis.
    Rami M; Atarhouch T; Dakkak A
    Vet Parasitol; 2005 Nov; 134(1-2):25-31. PubMed ID: 16076527
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of ELISA employing Leishmania (Viannia) braziliensis and Leishmania (Leishmania) chagasi antigens for the detection of IgG and IgG1 and IgG2 subclasses in the diagnosis of American tegumentary leishmaniasis in dogs.
    Ribeiro FC; de O Schubach A; Mouta-Confort E; Schubach TM; de Fátima Madeira M; Marzochi MC
    Vet Parasitol; 2007 Sep; 148(3-4):200-6. PubMed ID: 17689193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.